{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:49:57Z","timestamp":1775702997510,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"DOI":"10.1007\/s11274-026-04884-3","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:11:55Z","timestamp":1772791915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Restoration of \u03b2-lactam activity by nacubactam combinations against extensively drug-resistant K. pneumoniae\u00a0harbouring diverse carbapenem resistance gene"],"prefix":"10.1007","volume":"42","author":[{"given":"Dharmender","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahbaz","family":"Aman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafiul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"4884_CR1","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.2147\/IDR.S509016","volume":"18","author":"J Li","year":"2025","unstructured":"Li J, Shi Y, Song X, Yin X, Liu H (2025) Mechanisms of antimicrobial resistance in Klebsiella: advances in detection methods and clinical implications. Infect Drug Resist 18:1339\u201354. https:\/\/doi.org\/10.2147\/IDR.S509016","journal-title":"Infect Drug Resist"},{"key":"4884_CR2","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2147\/IDR.S453025","volume":"17","author":"Y Li","year":"2024","unstructured":"Li Y, Kumar S, Zhang L (2024) Mechanisms of antibiotic resistance and developments in therapeutic strategies to combat Klebsiella pneumoniae infection. Infect Drug Resist 17:1107\u201319. https:\/\/doi.org\/10.2147\/IDR.S453025","journal-title":"Infect Drug Resist"},{"key":"4884_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01949-23","author":"FR DeLeo","year":"2023","unstructured":"DeLeo FR, Porter AR, Kobayashi SD, Freedman B, Hao M, Jiang J et al (2023) Interaction of multidrug-resistant hypervirulent <Emphasis Type=\"Italic\">Klebsiella pneumoniae<\/Emphasis> with components of human innate host defense. MBio. https:\/\/doi.org\/10.1128\/mbio.01949-23","journal-title":"MBio"},{"key":"4884_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03679-6","volume":"24","author":"A Ferdosi-Shahandashti","year":"2024","unstructured":"Ferdosi-Shahandashti A, Pournajaf A, Ferdosi-Shahandashti E, Zaboli F, Javadi K (2024) Identification of beta-lactamase genes and molecular genotyping of multidrug-resistant clinical isolates of Klebsiella pneumoniae. BMC Microbiol 24:549. https:\/\/doi.org\/10.1186\/s12866-024-03679-6","journal-title":"BMC Microbiol"},{"key":"4884_CR5","doi-asserted-by":"publisher","unstructured":"Elshafiee EA, Kadry M, Nader SM, Ahmed ZS Extended-spectrum-beta-lactamases and carbapenemase-producing Klebsiella pneumoniae isolated from fresh produce farms in different governorates of Egypt. Vet World 2022:1191\u20131196. https:\/\/doi.org\/10.14202\/vetworld.2022.1191-1196","DOI":"10.14202\/vetworld.2022.1191-1196"},{"key":"4884_CR6","first-page":"283","volume":"9","author":"F Firoozeh","year":"2017","unstructured":"Firoozeh F, Mahluji Z, Shams E, Khorshidi A, Zibaei M (2017) New Delhi metallo-\u03b2-lactamase-1-producing Klebsiella pneumoniae isolates in hospitalized patients in Kashan, Iran. Iran J Microbiol 9:283\u2013287","journal-title":"Iran J Microbiol"},{"key":"4884_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-557","volume":"7","author":"A Bora","year":"2014","unstructured":"Bora A, Sanjana R, Jha BK, Narayan Mahaseth S, Pokharel K (2014) Incidence of metallo-beta-lactamase producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in central Nepal. BMC Res Notes 7:557. https:\/\/doi.org\/10.1186\/1756-0500-7-557","journal-title":"BMC Res Notes"},{"key":"4884_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84149-x","volume":"15","author":"HS Khalefa","year":"2025","unstructured":"Khalefa HS, Arafa AA, Hamza D, El-Razik KAA, Ahmed Z (2025) Emerging biofilm formation and disinfectant susceptibility of ESBL-producing Klebsiella pneumoniae. Sci Rep 15:1599. https:\/\/doi.org\/10.1038\/s41598-024-84149-x","journal-title":"Sci Rep"},{"key":"4884_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12919-019-0176-7","volume":"13","author":"H Nirwati","year":"2019","unstructured":"Nirwati H, Sinanjung K, Fahrunissa F, Wijaya F, Napitupulu S, Hati VP et al (2019) Biofilm formation and antibiotic resistance of Klebsiella pneumoniae isolated from clinical samples in a tertiary care hospital, Klaten, Indonesia. BMC Proc 13:20. https:\/\/doi.org\/10.1186\/s12919-019-0176-7","journal-title":"BMC Proc"},{"key":"4884_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00593-7","volume":"10","author":"R Ramakrishnan","year":"2024","unstructured":"Ramakrishnan R, Nair AV, Parmar K, Rajmani RS, Chakravortty D, Das D (2024) Combating biofilm-associated Klebsiella pneumoniae infections using a bovine microbial enzyme. NPJ Biofilms Microbiomes 10:119. https:\/\/doi.org\/10.1038\/s41522-024-00593-7","journal-title":"NPJ Biofilms Microbiomes"},{"key":"4884_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-01112-1","volume":"5","author":"X Huang","year":"2025","unstructured":"Huang X, Yao X, Hou Y, Zhang D, Xie R, Shi C et al (2025) Global trends of antimicrobial resistance and virulence of Klebsiella pneumoniae from different host sources. Commun Med 5:383. https:\/\/doi.org\/10.1038\/s43856-025-01112-1","journal-title":"Commun Med"},{"key":"4884_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14050528","volume":"14","author":"I Karaiskos","year":"2025","unstructured":"Karaiskos I, Galani I, Daikos GL, Giamarellou H (2025) Breaking through resistance: a comparative review of new beta-lactamase inhibitors (Avibactam, Vaborbactam, Relebactam) against multidrug-resistant superbugs. Antibiotics 14:528. https:\/\/doi.org\/10.3390\/antibiotics14050528","journal-title":"Antibiotics"},{"key":"4884_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.877995","author":"MES Guerra","year":"2022","unstructured":"Guerra MES, Destro G, Vieira B, Lima AS, Ferraz LFC, Hakansson AP et al (2022) Klebsiella pneumoniae biofilms and their role in disease pathogenesis. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2022.877995","journal-title":"Front Cell Infect Microbiol"},{"key":"4884_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01757-18","author":"MM Sfeir","year":"2019","unstructured":"Sfeir MM, Hayden JA, Fauntleroy KA, Mazur C, Johnson JK, Simner PJ et al (2019) EDTA-modified carbapenem inactivation method: a phenotypic method for detecting metallo-\u03b2-lactamase-producing <Emphasis Type=\"Italic\">Enterobacteriaceae<\/Emphasis>. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.01757-18","journal-title":"J Clin Microbiol"},{"key":"4884_CR15","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/JCM.00193-17","volume":"55","author":"VM Pierce","year":"2017","unstructured":"Pierce VM, Simner PJ, Lonsway DR, Roe-Carpenter DE, Johnson JK, Brasso WB et al (2017) Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae. J Clin Microbiol 55:2321\u201333. https:\/\/doi.org\/10.1128\/JCM.00193-17","journal-title":"J Clin Microbiol"},{"key":"4884_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-020-02010-3","volume":"20","author":"Y-M Tsai","year":"2020","unstructured":"Tsai Y-M, Wang S, Chiu H-C, Kao C-Y, Wen L-L (2020) Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae. BMC Microbiol 20:315. https:\/\/doi.org\/10.1186\/s12866-020-02010-3","journal-title":"BMC Microbiol"},{"key":"4884_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.21037\/atm.2019.09.43","volume":"7","author":"J Li","year":"2019","unstructured":"Li J, Li C, Cai X, Shi J, Feng L, Tang K et al (2019) Performance of modified carbapenem inactivation method and inhibitor-based combined disk test in the detection and distinguishing of carbapenemase producing Enterobacteriaceae. Ann Transl Med 7:566\u2013566. https:\/\/doi.org\/10.21037\/atm.2019.09.43","journal-title":"Ann Transl Med"},{"key":"4884_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02015-19","author":"CM Gill","year":"2020","unstructured":"Gill CM, Lasko MJ, Asempa TE, Nicolau DP (2020) Evaluation of the EDTA-modified carbapenem inactivation method for detecting metallo-\u03b2-lactamase-producing <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis>. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.02015-19","journal-title":"J Clin Microbiol"},{"key":"4884_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-020-01902-8","volume":"20","author":"MJ Lasko","year":"2020","unstructured":"Lasko MJ, Gill CM, Asempa TE, Nicolau DP (2020) EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-\u03b2-lactamase\u2013producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations. BMC Microbiol 20:220. https:\/\/doi.org\/10.1186\/s12866-020-01902-8","journal-title":"BMC Microbiol"},{"key":"4884_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50246-5","volume":"9","author":"R Martzy","year":"2019","unstructured":"Martzy R, Bica-Schr\u00f6der K, P\u00e1lv\u00f6lgyi \u00c1M, Kolm C, Jakwerth S, Kirschner AKT et al (2019) Simple lysis of bacterial cells for DNA-based diagnostics using hydrophilic ionic liquids. Sci Rep 9:13994. https:\/\/doi.org\/10.1038\/s41598-019-50246-5","journal-title":"Sci Rep"},{"key":"4884_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12941-024-00672-9","volume":"23","author":"E Karaman","year":"2024","unstructured":"Karaman E, \u00c7i\u00e7ek A\u00c7, \u015eemen V, \u015eaban Beri\u015f F (2024) Characterization of resistance genes and replicon typing in Carbapenem-resistant Klebsiella pneumoniae strains. Ann Clin Microbiol Antimicrob 23:19. https:\/\/doi.org\/10.1186\/s12941-024-00672-9","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"4884_CR22","doi-asserted-by":"publisher","DOI":"10.3791\/3923","author":"PY Lee","year":"2012","unstructured":"Lee PY, Costumbrado J, Hsu C-Y, Kim YH (2012) Agarose gel electrophoresis for the separation of DNA fragments. J Vis Exp. https:\/\/doi.org\/10.3791\/3923","journal-title":"J Vis Exp"},{"key":"4884_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s43088-023-00437-x","volume":"12","author":"I El Defrawy","year":"2023","unstructured":"El Defrawy I, Salem D, Ali G, Gamal D, El Dabaa E, Diab M et al (2023) Carbapenemase producing Enterobacterales clinical isolates from a tertiary care hospital in Egypt. Beni-Suef Univ J Basic Appl Sci 12:98. https:\/\/doi.org\/10.1186\/s43088-023-00437-x","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"4884_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119\u2013123. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.12.002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4884_CR25","doi-asserted-by":"publisher","unstructured":"Gurung S, Kafle S, Dhungel B, Adhikari N, Thapa Shrestha U, Adhikari B et al Detection of OXA-48 Gene in Carbapenem-Resistant\u2009<\u2009em>Escherichia coli\u2009and <em>Klebsiella pneumoniae<\/em> from Urine Samples. Infect Drug Resist 2020;Volume 13:2311\u20132321. https:\/\/doi.org\/10.2147\/IDR.S259967","DOI":"10.2147\/IDR.S259967"},{"key":"4884_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0300-5712(00)00039-7","volume":"28","author":"MG Botelho","year":"2000","unstructured":"Botelho MG (2000) Fractional inhibitory concentration index of combinations of antibacterial agents against cariogenic organisms. J Dent 28:565\u2013570. https:\/\/doi.org\/10.1016\/S0300-5712(00)00039-7","journal-title":"J Dent"},{"key":"4884_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/jac\/dkad033","volume":"78","author":"Y Igarashi","year":"2023","unstructured":"Igarashi Y, Takemura W, Liu X, Kojima N, Morita T, Chuang VTG et al (2023) Development of an optimized and practical pharmacokinetics\/pharmacodynamics analysis method for aztreonam\/nacubactam against carbapenemase-producing K. pneumoniae. J Antimicrob Chemother 78:991\u20139. https:\/\/doi.org\/10.1093\/jac\/dkad033","journal-title":"J Antimicrob Chemother"},{"key":"4884_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00585-21","author":"MM Montero","year":"2021","unstructured":"Montero MM, Domene Ochoa S, L\u00f3pez-Causap\u00e9 C, Luque S, Sorl\u00ed L, Campillo N et al (2021) Time-kill evaluation of antibiotic combinations containing ceftazidime-avibactam against extensively drug-resistant Pseudomonas aeruginosa and their potential role against ceftazidime-avibactam-resistant isolates. Microbiol Spectr. https:\/\/doi.org\/10.1128\/Spectrum.00585-21","journal-title":"Microbiol Spectr"},{"key":"4884_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1185450","author":"S Zhang","year":"2023","unstructured":"Zhang S, Mi P, Wang J, Li P, Luo K, Liu S et al (2023) The optimized carbapenem inactivation method for objective and accurate detection of carbapenemase-producing Acinetobacter baumannii. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1185450","journal-title":"Front Microbiol"},{"key":"4884_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-022-02110-3","volume":"11","author":"T Tesfa","year":"2022","unstructured":"Tesfa T, Mitiku H, Edae M, Assefa N (2022) Prevalence and incidence of carbapenem-resistant K. pneumoniae colonization: systematic review and meta-analysis. Syst Rev 11:240. https:\/\/doi.org\/10.1186\/s13643-022-02110-3","journal-title":"Syst Rev"},{"key":"4884_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/SMJ.0b013e3181fd7d5a","volume":"104","author":"RS Arnold","year":"2011","unstructured":"Arnold RS, Thom KA, Sharma S, Phillips M, Kristie Johnson J, Morgan DJ (2011) Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria. South Med J 104:40\u201345. https:\/\/doi.org\/10.1097\/SMJ.0b013e3181fd7d5a","journal-title":"South Med J"},{"key":"4884_CR32","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1128\/AAC.01019-15","volume":"59","author":"JDD Pitout","year":"2015","unstructured":"Pitout JDD, Nordmann P, Poirel L (2015) Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59:5873\u20135884. https:\/\/doi.org\/10.1128\/AAC.01019-15","journal-title":"Antimicrob Agents Chemother"},{"key":"4884_CR33","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1093\/jac\/dkae227","volume":"79","author":"Q Shi","year":"2024","unstructured":"Shi Q, Ruan Z, Zhang P, Hu H, Han X, Wang Z et al (2024) Epidemiology of carbapenem-resistant Klebsiella pneumoniae in China and the evolving trends of predominant clone ST11: a multicentre, genome-based study. J Antimicrob Chemother 79:2292\u20137. https:\/\/doi.org\/10.1093\/jac\/dkae227","journal-title":"J Antimicrob Chemother"},{"key":"4884_CR34","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.22207\/JPAM.17.4.07","volume":"17","author":"SS Cheemala","year":"2023","unstructured":"Cheemala SS, Vara A, Lakshmi MS, Pradhan S, Kalyani K (2023) Phenotypic detection of carbapenemase production in gram negative bacilli from clinical isolates in a tertiary care hospital in Telangana. J Pure Appl Microbiol 17:2111\u20132118. https:\/\/doi.org\/10.22207\/JPAM.17.4.07","journal-title":"J Pure Appl Microbiol"},{"key":"4884_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1096987","author":"X Jing","year":"2023","unstructured":"Jing X, Hu Y, Wu T, Zhang X, Luo S, Wang W et al (2023) A rapid method for detecting and distinguishing metallo-\u03b2-lactamase-and serine carbapenemase-producing Enterobacteriales using MALDI-TOF MS. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.1096987","journal-title":"Front Microbiol"},{"key":"4884_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/21505594.2016.1185577","volume":"8","author":"R Banerjee","year":"2017","unstructured":"Banerjee R, Humphries R (2017) Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae. Virulence 8:427\u2013439. https:\/\/doi.org\/10.1080\/21505594.2016.1185577","journal-title":"Virulence"},{"key":"4884_CR37","first-page":"199","volume":"10","author":"M Bina","year":"2015","unstructured":"Bina M, Pournajaf A, Mirkalantari S, Talebi M, Irajian G (2015) Detection of the Klebsiella pneumoniae carbapenemase (KPC) in K. pneumoniae isolated from the clinical samples by the phenotypic and genotypic methods. Iran J Pathol 10:199\u2013205","journal-title":"Iran J Pathol"},{"key":"4884_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00397-20","author":"SE Boyd","year":"2020","unstructured":"Boyd SE, Livermore DM, Hooper DC, Hope WW (2020) Metallo-\u03b2-Lactamases: structure, function, epidemiology, treatment options, and the development pipeline. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00397-20","journal-title":"Antimicrob Agents Chemother"},{"key":"4884_CR39","doi-asserted-by":"publisher","first-page":"093","DOI":"10.4103\/0974-2727.86841","volume":"3","author":"DG Deshmukh","year":"2011","unstructured":"Deshmukh DG, Damle AS, Bajaj JK, Bhakre JB, Patwardhan NS (2011) Metallo-\u03b2-lactamase-producing clinical isolates from patients of a tertiary care hospital. J Lab Physicians 3:093\u2013097. https:\/\/doi.org\/10.4103\/0974-2727.86841","journal-title":"J Lab Physicians"},{"key":"4884_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3947\/ic.2015.47.2.81","volume":"47","author":"DJ Hong","year":"2015","unstructured":"Hong DJ, Bae IK, Jang I-H, Jeong SH, Kang H-K, Lee K (2015) Epidemiology and characteristics of metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa. Infect Chemother 47:81. https:\/\/doi.org\/10.3947\/ic.2015.47.2.81","journal-title":"Infect Chemother"},{"key":"4884_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49349-z","volume":"15","author":"M Budia-Silva","year":"2024","unstructured":"Budia-Silva M, Kostyanev T, Ayala-Monta\u00f1o S, Bravo-Ferrer Acosta J, Garcia-Castillo M, Cant\u00f3n R et al (2024) International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe. Nat Commun 15:5092. https:\/\/doi.org\/10.1038\/s41467-024-49349-z","journal-title":"Nat Commun"},{"key":"4884_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2022.106536","volume":"200","author":"\u015e \u00c7al\u0131k","year":"2022","unstructured":"\u00c7al\u0131k \u015e, Kansak N, Aksaray S (2022) Phenotypic detection of carbapenemase production in carbapenem-resistant isolates with the rapid carbapenemase detection method (rCDM). J Microbiol Methods 200:106536. https:\/\/doi.org\/10.1016\/j.mimet.2022.106536","journal-title":"J Microbiol Methods"},{"key":"4884_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0318852","volume":"20","author":"A Pruss","year":"2025","unstructured":"Pruss A, Skierska A, Kwiatkowski P, Masiuk H, Jursa-Kulesza J, Giedrys-Kalemba S et al (2025) Comparative analysis of selected methods of carbapenemase determination among clinical Klebsiella pneumoniae. PLoS One 20:e0318852. https:\/\/doi.org\/10.1371\/journal.pone.0318852","journal-title":"PLoS One"},{"key":"4884_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.15537\/smj.2022.43.3.20210809","volume":"43","author":"SK Vamsi","year":"2022","unstructured":"Vamsi SK, Moorthy RS, Hemiliamma MN, Chandra Reddy RB, chanderakant DJ, Sirikonda S (2022) Phenotypic and genotypic detection of carbapenemase production among gram negative bacteria isolated from hospital acquired infections. Saudi Med J 43:236\u2013243. https:\/\/doi.org\/10.15537\/smj.2022.43.3.20210809","journal-title":"Saudi Med J"},{"key":"4884_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13050435","volume":"13","author":"DS Lazar","year":"2024","unstructured":"Lazar DS, Nica M, Dascalu A, Oprisan C, Albu O, Codreanu DR et al (2024) Carbapenem-resistant NDM and OXA-48-like producing K. pneumoniae: from menacing superbug to a mundane bacteria; a retrospective study in a Romanian Tertiary Hospital. Antibiotics 13:435. https:\/\/doi.org\/10.3390\/antibiotics13050435","journal-title":"Antibiotics"},{"key":"4884_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70910-9","volume":"14","author":"KT Salvador-Oke","year":"2024","unstructured":"Salvador-Oke KT, Pitout JDD, Peirano G, Strydom K-A, Kingsburgh C, Ehlers MM et al (2024) Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in Gauteng South Africa. Sci Rep 14:27337. https:\/\/doi.org\/10.1038\/s41598-024-70910-9","journal-title":"Sci Rep"},{"key":"4884_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14020141","volume":"14","author":"G Alvisi","year":"2025","unstructured":"Alvisi G, Curtoni A, Fonnesu R, Piazza A, Signoretto C, Piccinini G et al (2025) Epidemiology and genetic traits of carbapenemase-producing Enterobacterales: a global threat to human health. Antibiotics 14:141. https:\/\/doi.org\/10.3390\/antibiotics14020141","journal-title":"Antibiotics"},{"key":"4884_CR48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jgar.2022.01.001","volume":"28","author":"G Lorenzin","year":"2022","unstructured":"Lorenzin G, Gona F, Battaglia S, Spitaleri A, Saluzzo F, Trovato A et al (2022) Detection of NDM-1\/5 and OXA-48 co-producing extensively drug-resistant hypervirulent Klebsiella pneumoniae in Northern Italy. J Glob Antimicrob Resist 28:146\u201350. https:\/\/doi.org\/10.1016\/j.jgar.2022.01.001","journal-title":"J Glob Antimicrob Resist"},{"key":"4884_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13071697","volume":"13","author":"ME Falagas","year":"2025","unstructured":"Falagas ME, Asimotou C-M, Zidrou M, Kontogiannis DS, Filippou C (2025) Global epidemiology and antimicrobial resistance of Klebsiella pneumoniae carbapenemase (KPC)-producing Gram-negative clinical isolates: a review. Microorganisms 13:1697. https:\/\/doi.org\/10.3390\/microorganisms13071697","journal-title":"Microorganisms"},{"key":"4884_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00008-24","author":"P-B Yuan","year":"2024","unstructured":"Yuan P-B, Dai L-T, Zhang Q-K, Zhong Y-X, Liu W-T, Yang L et al (2024) Global emergence of double and multi-carbapenemase producing organisms: epidemiology, clinical significance, and evolutionary benefits on antimicrobial resistance and virulence. Microbiol Spectr. https:\/\/doi.org\/10.1128\/spectrum.00008-24","journal-title":"Microbiol Spectr"},{"key":"4884_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127249","volume":"266","author":"J Ma","year":"2023","unstructured":"Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z et al (2023) Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res 266:127249. https:\/\/doi.org\/10.1016\/j.micres.2022.127249","journal-title":"Microbiol Res"},{"key":"4884_CR52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4314\/ahs.v21i2.2","volume":"21","author":"R Ahmed El-Domany","year":"2021","unstructured":"Ahmed El-Domany R, El-Banna T, Sonbol F, Hamed Abu-Sayedahmed S (2021) Co-existence of NDM-1 and OXA-48 genes in Carbapenem Resistant Klebsiella pneumoniae clinical isolates in Kafrelsheikh, Egypt. Afr Health Sci 21:489\u2013496. https:\/\/doi.org\/10.4314\/ahs.v21i2.2","journal-title":"Afr Health Sci"},{"key":"4884_CR53","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4103\/JLP.JLP_111_19","volume":"11","author":"P Remya","year":"2019","unstructured":"Remya P, Shanthi M, Sekar U (2019) Prevalence and clonal relatedness of NDM and OXA-48-producing Klebsiella pneumoniae in a tertiary care hospital in South India. J Lab Physicians 11:312\u2013316. https:\/\/doi.org\/10.4103\/JLP.JLP_111_19","journal-title":"J Lab Physicians"},{"key":"4884_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00314","author":"R Han","year":"2020","unstructured":"Han R, Shi Q, Wu S, Yin D, Peng M, Dong D et al (2020) Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2020.00314","journal-title":"Front Cell Infect Microbiol"},{"key":"4884_CR55","doi-asserted-by":"publisher","unstructured":"Shakhatreh MA, Al-Ghawrie H, Meqdam M, Shakhatreh Z, Khair I, Tabnjh A et al Possible Association of Carbapenemase Production with Susceptibility Pattern and Resistance Genes Among Carbapenemase Producing Enterobacterales from Blood Isolates or Bacteremic Patients. Infect Drug Resist 2025;Volume 18:2569\u20132579. https:\/\/doi.org\/10.2147\/IDR.S519561","DOI":"10.2147\/IDR.S519561"},{"key":"4884_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv050","author":"HJ Morrill","year":"2015","unstructured":"Morrill HJ, Pogue JM, Kaye KS, LaPlante KL (2015) Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofv050","journal-title":"Open Forum Infect Dis"},{"key":"4884_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaa075","author":"S Hughes","year":"2020","unstructured":"Hughes S, Gilchrist M, Heard K, Hamilton R, Sneddon J (2020) Treating infections caused by carbapenemase-producing Enterobacterales (CPE): a pragmatic approach to antimicrobial stewardship on behalf of the UKCPA Pharmacy Infection Network (PIN). JAC-Antimicrobial Resistance. https:\/\/doi.org\/10.1093\/jacamr\/dlaa075","journal-title":"JAC-Antimicrobial Resistance"},{"key":"4884_CR58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.37201\/req\/s03.11.2022","volume":"35","author":"M Chumbita","year":"2022","unstructured":"Chumbita M, Monzo-Gallo P, Lopera-M\u00e1rmol C, Aiello TF, Puerta-Alcalde P, Garcia-Vidal C (2022) Treatment of infections caused by carbapenemase-producing Enterobacterales. Rev Esp Quimioter 35:46\u201350. https:\/\/doi.org\/10.37201\/req\/s03.11.2022","journal-title":"Rev Esp Quimioter"},{"key":"4884_CR59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s15010-016-0968-x","volume":"45","author":"R Murri","year":"2017","unstructured":"Murri R, Fiori B, Spanu T, Mastrorosa I, Giovannenze F, Taccari F et al (2017) Trimethoprim\u2013sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. Infection 45:209\u201313. https:\/\/doi.org\/10.1007\/s15010-016-0968-x","journal-title":"Infection"},{"key":"4884_CR60","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1556\/030.2025.02577","volume":"72","author":"C Xu","year":"2025","unstructured":"Xu C (2025) Antibacterial efficacy of cefoperazone\/sulbactam in combination with various antimicrobials against carbapenem-resistant Klebsiella pneumoniae. Acta Microbiol Immunol Hung 72:106\u201312. https:\/\/doi.org\/10.1556\/030.2025.02577","journal-title":"Acta Microbiol Immunol Hung"},{"key":"4884_CR61","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00972-23","author":"M Hussein","year":"2024","unstructured":"Hussein M, Sun Z, Hawkey J, Allobawi R, Judd LM, Carbone V et al (2024) High-level nitrofurantoin resistance in a clinical isolate of <Emphasis Type=\"Italic\">Klebsiella pneumoniae<\/Emphasis>: a comparative genomics and metabolomics analysis. mSystems. https:\/\/doi.org\/10.1128\/msystems.00972-23","journal-title":"mSystems"},{"key":"4884_CR62","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy351","author":"CL Luterbach","year":"2019","unstructured":"Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA et al (2019) The role of trimethoprim\/sulfamethoxazole in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofy351","journal-title":"Open Forum Infect Dis"},{"key":"4884_CR63","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00432-19","author":"MD Barnes","year":"2019","unstructured":"Barnes MD, Taracila MA, Good CE, Bajaksouzian S, Rojas LJ, van Duin D et al (2019) Nacubactam enhances meropenem activity against carbapenem-resistant Klebsiella pneumoniae producing KPC. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00432-19","journal-title":"Antimicrob Agents Chemother"},{"key":"4884_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02382-18","author":"TE Asempa","year":"2019","unstructured":"Asempa TE, Motos A, Abdelraouf K, Bissantz C, Zampaloni C, Nicolau DP (2019) Efficacy of human-simulated epithelial lining fluid exposure of meropenem-nacubactam combination against class A serine \u03b2-lactamase-producing <Emphasis Type=\"Italic\">Enterobacteriaceae<\/Emphasis> in the neutropenic murine lung infection model. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02382-18","journal-title":"Antimicrob Agents Chemother"},{"key":"4884_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy210.705","volume":"5","author":"MD Barnes","year":"2018","unstructured":"Barnes MD, Good CE, Bajaksouzian S, Taracila MA, Van Duin D, Kreiswirth BN et al (2018) 698. Nacubactam inhibits class A \u03b2-lactamases. Open Forum Infect Dis 5:S251. https:\/\/doi.org\/10.1093\/ofid\/ofy210.705","journal-title":"Open Forum Infect Dis"},{"key":"4884_CR66","doi-asserted-by":"publisher","unstructured":"Hoff JF, Goudar KE, Beer M, Hinchliffe P, Shaw JM, Tooke CL et al Electrostatic interactions define nacubactam potency against OXA-48-like \u03b2-lactamases 2024. https:\/\/doi.org\/10.1101\/2024.10.30.621041","DOI":"10.1101\/2024.10.30.621041"},{"key":"4884_CR67","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02596-17","author":"ML Monogue","year":"2018","unstructured":"Monogue ML, Giovagnoli S, Bissantz C, Zampaloni C, Nicolau DP (2018) <Emphasis Type=\"Italic\">In vivo<\/Emphasis> efficacy of meropenem with a novel non-\u03b2-lactam\u2013\u03b2-lactamase inhibitor, nacubactam, against gram-negative organisms exhibiting various resistance mechanisms in a murine complicated urinary tract infection model. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02596-17","journal-title":"Antimicrob Agents Chemother"},{"key":"4884_CR68","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1021\/acs.jmedchem.9b01279","volume":"63","author":"C Gonz\u00e1lez-Bello","year":"2020","unstructured":"Gonz\u00e1lez-Bello C, Rodr\u00edguez D, Pernas M, Rodr\u00edguez \u00c1, Colch\u00f3n E (2020) \u03b2-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs. J Med Chem 63:1859\u20131881. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01279","journal-title":"J Med Chem"},{"key":"4884_CR69","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02229-19","author":"NL Mallalieu","year":"2020","unstructured":"Mallalieu NL, Winter E, Fettner S, Patel K, Zwanziger E, Attley G et al (2020) Safety and pharmacokinetic characterization of nacubactam, a novel \u03b2-lactamase inhibitor, alone and in combination with meropenem, in healthy volunteers. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02229-19","journal-title":"Antimicrob Agents Chemother"},{"key":"4884_CR70","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jac\/dkae443","volume":"80","author":"Y Igarashi","year":"2025","unstructured":"Igarashi Y, Taguchi K, Enoki Y, Chuang VTG, Matsumoto K (2025) Simulated achievement rate of \u03b2-lactams\/nacubactam treatment in humans using instantaneous MIC-based PK\/PD analysis. J Antimicrob Chemother 80:547\u2013553. https:\/\/doi.org\/10.1093\/jac\/dkae443","journal-title":"J Antimicrob Chemother"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-04884-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-026-04884-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-04884-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:03:48Z","timestamp":1775700228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-026-04884-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4884"],"URL":"https:\/\/doi.org\/10.1007\/s11274-026-04884-3","relation":{},"ISSN":["1573-0972"],"issn-type":[{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}